{
    "nct_id": "NCT03968913",
    "official_title": "Biologic Therapy to Prevent Osteoarthritis After ACL Injury",
    "inclusion_criteria": "* patients age 18 to 35 years with closed growth plates as visualized on plain radiographs who participate in cutting and pivoting activities.\n* we will enroll an equal number of men and women in each treatment group (16 total per group; 8 men, 8 women).\n* study participants must have an MRI-confirmed ACL injury within 2 weeks of presentation\n* must elect to undergo bone-patellar tendon-bone (BTB) autograft ACL reconstruction within 45 days of injury\n* no clinical or MRI evidence of posterior cruciate ligament injury\n* no more than grade 1 medial collateral ligament injury\n* no concurrent posterolateral corner injury to the ipsilateral knee\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 35 Years",
    "exclusion_criteria": "* injury occurring more than 2 weeks prior to enrollment\n* previous ipsilateral knee injury\n* multi-ligamentous knee injury\n* pre-existing or concurrent grade 3 or 4 chondral (cartilage) injuries\n* previous ipsilateral knee surgery (meniscus tear, ACL tear, chondral injury, etc.)\n* of note, concurrent acute meniscus injury is NOT an exclusion criteria\n* active infection\n* known allergy or adverse reaction to anakinra\n* intra-articular cortisone injection into either knee within 3 months of injury\n* prior exposure to IL-1Ra\n* participation in another clinical drug trial within the 4 weeks before injury\n* history of any coagulopathy or current anti-coagulation therapy\n* current malignancy\n* current inflammatory/rheumatologic disease\n* current immune-compromised state\n* current renal failure",
    "miscellaneous_criteria": ""
}